Related Experiment Video
Updated: Jan 9, 2026

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
Identification and experimental validation of biomarkers associated with macrophages in myocardial
Xiaojie Jiang1, Liyun Liu1, Jianxin Huang1
1Department of Cardiology, The First Hospital of Nanchang, Nanchang, China.
Abstract:
Myocardial ischemia-reperfusion injury (MIRI) is a complex process leading to substantial myocardial damage. Macrophages play a pivotal role in tissue development and homeostasis. This study aimed to identify macrophage-associated biomarkers in MIRI and explore the molecular mechanisms underlying their involvement. Macrophage-related genes (MRGs) were retrieved from public databases, and differentially expressed genes (DEGs) were identified using transcriptomic data. MRGs and DEGs were integrated to identify candidate genes. Biomarkers were identified through protein-protein interaction (PPI) analysis and gene expression validation. Enrichment analysis, immune infiltration analysis, construction of molecular regulatory networks, drug prediction, and molecular docking were conducted to investigate the functional mechanisms of the identified biomarkers. Additionally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed. Finally, single-cell data were analyzed to assess the distribution of biomarkers across annotated cell types. Tlr7, Tlr1, Tlr6, and Il33 were identified as key biomarkers. Enrichment analysis revealed that the "Ribosome," "Oxidative phosphorylation," and "Spliceosome" pathways were significantly enriched in these biomarkers. Immune infiltration analysis demonstrated distinct differences in the presence of macrophages, M1 macrophages, and M2 macrophages between MIRI and control groups. Notably, Tlr7, Tlr1, and Tlr6 exhibited strong positive correlations with macrophages, M1, and M2 macrophages. Biomarkers were regulated by several transcription factors (TFs) (e.g., MYC, TBP) and microRNAs (miRNAs) (e.g., -mmu-miR-15a-5p). Drug prediction and molecular docking analyses indicated that IMIQUIMOD and Acetaminophen might serve as potential therapeutic targets for MIRI. RT-qPCR confirmed significant upregulation of Tlr7, Tlr1, and Tlr6 in the MIRI group, consistent with bioinformatics findings, whereas Il33 showed no significant difference between the two groups. Five major cell types were identified, including pericytes, M2 macrophages, and M1 macrophages. Notably, Tlr7 and Tlr1 were predominantly expressed in M2 macrophages. Tlr7, Tlr1, Tlr6, and Il33 were identified as macrophage-associated biomarkers in MIRI, providing valuable insights for MIRI diagnosis and potential therapeutic interventions.
Insights
This study identifies Tlr7, Tlr1, Tlr6, and Il33 as key macrophage-associated biomarkers for myocardial ischemia-reperfusion injury (MIRI). These findings offer insights into MIRI mechanisms and potential therapeutic targets for improved patient outcomes.
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Myocardial ischemia-reperfusion injury (MIRI) causes significant heart damage.
- Macrophages are crucial in tissue repair and homeostasis, influencing MIRI outcomes.
Purpose of the Study:
- To identify macrophage-related genes (MRGs) as biomarkers for MIRI.
- To explore the molecular mechanisms and regulatory networks of these biomarkers in MIRI.
Main Methods:
- Integrated transcriptomic data with MRGs to identify candidate genes.
- Utilized protein-protein interaction analysis, enrichment analysis, and immune infiltration analysis.
- Validated findings using RT-qPCR and analyzed single-cell data for biomarker distribution.
Main Results:
- Identified Tlr7, Tlr1, Tlr6, and Il33 as key macrophage-associated biomarkers in MIRI.
- Found significant enrichment in "Ribosome," "Oxidative phosphorylation," and "Spliceosome" pathways.
- Tlr7, Tlr1, and Tlr6 showed positive correlations with macrophage subtypes and were upregulated in MIRI; Tlr7 and Tlr1 were mainly expressed in M2 macrophages.
Conclusions:
- Tlr7, Tlr1, Tlr6, and Il33 are valuable macrophage-associated biomarkers for MIRI diagnosis.
- Identified potential therapeutic targets, including IMIQUIMOD and Acetaminophen, for MIRI treatment.
- The study provides a foundation for understanding macrophage roles in MIRI pathogenesis and developing targeted therapies.

